SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is trending following an FDA announcement of decisive action against mass-marketed, non-FDA-approved compounded GLP-1 drugs, resulting in a Department of Justice referral for the company. This move has polarized the community, with many predicting further stock declines as "justice" for "copycat" drugs, while others view it as an overblown reaction and a buying opportunity, citing potential market manipulation by larger pharmaceutical rivals.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

WEEDCOIN CRYPTO is trending as its community on Solana anticipates the approaching 4/20 cannabis holiday, fueling discussions around its mission to destigmatize cannabis culture and promote full-plant legalization through blockchain. Enthusiasts are focused on long-term growth, strategic accumulation via platform fees, and establishing a "Weed3" culture layer for global impact.

PepsiCo, Inc. engages in the manufacture, marketing, distribution, and sale of beverages, food, and snacks. It operates through the following business segments: PepsiCo Foods North America (PFNA), PepsiCo Beverages North America (PBNA), International Beverages Franchise (IB Franchise), Europe, Middle East and Africa (EMEA), Latin America Foods (LatAm Foods), and Asia Pacific Foods. The PFNA segment refers to the food businesses in the United States and Canada. The PBNA segment includes beverage businesses in the United States and Canada. The IB Franchise segment involves international franchise beverage businesses, as well as the SodaStream business. The EMEA segment pertains to food businesses and beverage businesses with company-owned bottlers in Europe, the Middle East, and Africa. The LatAm Foods segment consists of food businesses in Latin America. The Asia Pacific Foods segment is associated in food businesses in Asia Pacific, including China, Australia and New Zealand, as well as India. The company was founded by Donald M. Kendall, Sr. and Herman W. Lay in 1965 and is headquartered in Purchase, NY.

PepsiCo Inc

PepsiCo is trending following a strong Q4 earnings beat, a significant dividend increase, and a new share buyback program, reinforcing its status as a defensive play with the community also discussing analyst upgrades and its strategic move to reduce snack prices and optimize operations after engagement with an activist investor.

Rubrik, Inc. engages in the provision of cloud data management solutions. Its solutions include backup and recovery, VM backup, Microsoft 365, ransom ware recovery, database backup, cloud solutions, and Polaris sonar. Rubrik products include data protection, data threat analytics, data security posture and cyber recovery. The company was founded by Bipul Sinha, Arvind Jain, Soham Mazumdar, and Arvind Nithrakashyap in December 2013 and is headquartered in Palo Alto, CA.

Rubrik Inc. - Ordinary Shares - Class A

Rubrik Inc. - Class A

Rubrik (RBRK) is surging after announcing strong preliminary Q4/FY2026 results and its first-ever non-GAAP profit, significantly exceeding expectations and fueling bullish sentiment. The community believes the stock was previously undervalued, now highlighting its leadership in cyber resilience and AI data protection amidst a broader software sector struggle.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is seeing renewed investor interest after the FDA announced decisive action against companies mass-marketing illegal, compounded GLP-1 drugs, a move widely interpreted by the community as protecting NVO's patented Wegovy offerings from cheaper copycats.

Zscaler, Inc. engages in the provision of a cloud-based internet security platform. It offers Zero Trust Exchange, Zscaler Client Connector, Zscaler Internet Access, Zscaler Private Access, Zscaler B2B, Zscaler Cloud Protection, and Zscaler Digital Experience. The company was founded by Jagtar Singh Chaudhry and K. Kailash in September 2007 and is headquartered in San Jose, CA.

Zscaler Inc

Zscaler is currently undergoing a perplexing sell-off post-earnings, defying solid results and subsequent analyst upgrades. Community discussion is split between those buying the dip due to strong fundamentals and oversold conditions, and others frustrated by the 'illogical' price action, amidst broader software sector rotation and mixed views on AI's impact on cybersecurity.

Stellantis NV engages in the designing, engineering, manufacturing, distributing, and selling of vehicles and components. It offers its products under the Abarth, Alfa Romeo, Chrysler, Citroën, Dodge, DS Automobiles, Fiat, Jeep, Lancia, Maserati, Opel, Peugeot, Ram Trucks, Vauxhall, Free2move, and Leasys brands. The company was founded on April 1, 2014 and is headquartered in Hoofddorp, the Netherlands.

Stellantis N.V

Stellantis is trending following a significant write-down and dividend suspension tied to a strategic reset of its EV plans, prompting polarized community discussion about the pivot towards profitable ICE and hybrid vehicles amidst broader auto sector challenges and speculation over new U.S. investments and potential tariff changes.

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Intuitive Surgical Inc

Intuitive Surgical is trending after reporting strong Q3 earnings with significant growth across its da Vinci and Ion robotic procedure volumes, complemented by recent FDA clearances for its advanced surgical systems. The market is actively discussing its expanding market dominance and numerous analyst upgrades, although some investors are debating its current high valuation amidst recent price fluctuations.

Caterpillar, Inc. engages in the business of manufacturing construction and mining equipment, off-highway diesel and natural gas engines, industrial gas turbines, and diesel-electric locomotives. It operates through the following segments: Construction Industries, Resource Industries, Energy and Transportation, Financial Products, and All Other. The Construction Industries segment is involved in supporting customers using machinery in infrastructure and building construction applications. The Resource Industries segment offers machinery in mining, heavy construction, quarry, and aggregates. The Energy and Transportation segment focuses on reciprocating engines, turbines, diesel-electric locomotives, and related services across industries serving oil and gas, power generation, industrial, and transportation applications including marine- and rail-related businesses. The Financial Products segment provides financing alternatives to customers and dealers for Caterpillar products and services, as well as financing for power generation facilities. The All Other segment includes activities such as the business strategy, product management and development, manufacturing, and sourcing of wear and maintenance components products, parts distribution, integrated logistics solutions, distribution services responsible for dealer development, and administration. The company was founded on April 15, 1925 and is headquartered in Irving, TX.

Caterpillar Inc.

Surging demand for Caterpillar's power generation equipment and industrial machinery for AI data centers is driving robust growth and a record backlog, fueling a strong rally while sparking community discussion about its valuation and increasingly overbought technicals.

Roku, Inc. engages in the provision of a streaming platform for television. It operates through the Platform and Devices segments. The Platform segment includes digital advertising and related services including the demand-side platform and content distribution services such as subscription and transaction revenue shares, media and entertainment promotional spending, the sale of premium subscriptions, and the sale of branded channel buttons on remote controls. The Devices segment is involved in the sale of streaming players, audio products, smart home products, and accessories that are sold through retailers and distributors, as well as directly to customers through the company’s website. The company was founded by Anthony J. Wood in October 2002 and is headquartered in San Jose, CA.

Roku Inc - Ordinary Shares - Class A

Roku Inc

Roku is trending due to a flurry of analyst upgrades with significantly raised price targets, including a notable double upgrade from Morgan Stanley, citing accelerating platform revenue, a strengthening ad ecosystem, and growing streaming market share. The community is actively discussing these positive catalysts and anticipating strong upcoming earnings, though many express frustration over the stock's perceived underperformance amidst the bullish news and ongoing speculation about potential acquisitions.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Pulse Biosciences (NASDAQ:PLSE) Shares Gap Up - Here's What Happened

Pulse Biosciences (NASDAQ:PLSE) Shares Gap Up - Still a Buy...

Pulse Biosciences Presents Late-Breaking Data from nPulse Cardiac Catheter System First-In-Human Feasibility Study at the AF Symposium

Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of the novel nPulse technology using proprietary Nanosecond Pulsed Field Ablation (nanosecond PFA or nsPFA) energy, today announced late-breaking...

Pulse Biosciences nPulse Cardiac Catheter to Be Featured in Multiple Presentations at the AF Symposium

Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse technology using its proprietary Nanosecond Pulsed Field Ablation (nanosecond PFA or nsPFA) energy, today announced its...

Mizuho Initiates Coverage on Pulse Biosciences (NASDAQ:PLSE)

Mizuho started coverage on shares of Pulse Biosciences in a research report on Friday. They issued an "outperform" rating and a $25.00 price target on the stock...

Pulse Biosciences (NASDAQ:PLSE) Stock Price Down 1.4% - Here's What Happened

Pulse Biosciences (NASDAQ:PLSE) Stock Price Down 1.4% - Here's Why...

Pulse Biosciences Selected to Present Late-Breaking Data from the nPulse Cardiac Catheter Study at the AF Symposium

Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse technology using its proprietary Nanosecond Pulsed Field Ablation (nanosecond PFA or nsPFA) energy, today announced that...

Pulse Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference

Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse technology using its proprietary Nanosecond Pulsed Field Ablation (nanosecond PFA or nsPFA) energy, today announced plans...

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

PLSE Wins FDA IDE Approval to Launch nPulse AF Ablation Study Trial

PLSE has secured FDA IDE approval to launch its nPulse AF ablation study.

Pulse Biosciences (NASDAQ:PLSE) Trading Up 5% - Here's What Happened

Pulse Biosciences (NASDAQ:PLSE) Trading 5% Higher - Time to Buy...

Pulse Biosciences, Inc. operates as an immuno-oncology company developing a proprietary oncolytic electroceutical therapy based on its Nano Pulse Stimulation (NPS) technology. It manufactures surgical and medical instruments using a novel and proprietary platform technology called Nano-Pulse Electro-Signaling. The NPES provides local tumor control and initiates an adaptive immune response with a vaccine-like effect by inducing immunogenic apoptosis of the cells. The company was founded on May 19, 2014 and is headquartered in Miami, FL.

Pulse Biosciences Inc

Up 5%

Down 5%

Markets are hovering near key levels, making the next 5% move especially important for sentiment. A breakout higher could reinforce the bull case, while a 5% drop may signal rising risk and tighter conditions. Which comes first?

What will be the S&amp;P 500’s next 5% move?

Stocktwits

What will be the S&P 500’s next 5% move?

Stocktwits Polls

Traders are anticipating a significant upward movement, eyeing resistance levels around $20-$30 for a major surge with many predicting prices reaching $50 or even $100.

Excitement surrounds positive clinical trial results for its nPulse cardiac catheter ablation technology, boasting 100% procedural success in evaluable patients.

Speculation is building around a potential short squeeze due to a thinly traded float, with a reported 80% insider ownership suggesting explosive price action.

Current Price	$21.91
Prev Close	$13.69
Open	$14.95
Dividend Yield	0.00%
50-Day Moving Average	$14.10
Beta	1.29
Avg. Volume	165,658.80
PE Ratio	-12.06

52-Week High	$22.75
52-Week Low	$12.56
Market Capitalization	$927.74M
EPS (Annual)	-$0.9176
Price to Book	10.00
Revenue Per Employee	$0.00
Enterprise Value/EBITDA	N/A

PLSE
Pulse Biosciences Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest PLSE News

PLSEPulse Biosciences Inc